Hinge Health, Inc. (HNGE) stock is soaring 22.66% in its New York Stock Exchange debut on Thursday, following a successful initial public offering (IPO) that raised $437 million. The digital health startup, which specializes in joint and muscle pain treatment, priced its shares at $32 each, the top end of its marketed range.
The company sold approximately 13.7 million shares, with about 8.5 million offered by Hinge Health itself and the remainder by existing shareholders. The strong debut reflects investor confidence in the company's business model and growth potential in the digital health sector.
Hinge Health's impressive first-day performance comes amid a resurgence in the IPO market. The company's successful listing, along with other recent IPOs, signals a renewed appetite for new issues despite ongoing market volatility. This positive reception could encourage other companies waiting in the wings to move forward with their public offerings.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。